Relapsed/refractory marginal zone lymphoma (r/r mzl) Clinical Trials
Conditions / Relapsed/refractory marginal zone lymphoma (r/r mzl)
Delta Trials catalogs 1 clinical trial for Relapsed/refractory marginal zone lymphoma (r/r mzl) in its publicly accessible dataset. Within this set, 1 currently recruiting participants and 0 trials have reached completion. This research occurs across 141 participating sites around the world. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
1
Total Trials
1
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
141
Study Locations
Browse by location (141 total)
- Uxbridge, United Kingdom 1 trialAll trials in Uxbridge, United Kingdom
- Busan, South Korea 1 trialAll trials in Busan, South Korea
- Ulsan, South Korea 1 trialAll trials in Ulsan, South Korea
- Kuala Lumpur, Malaysia 1 trialAll trials in Kuala Lumpur, Malaysia
- Taoyuan, Taiwan 1 trialAll trials in Taoyuan, Taiwan
- Jaú, Brazil 1 trialAll trials in Jaú, Brazil
- Jaú, Brazil 1 trialAll trials in Jaú, Brazil
- Jaú, Brazil 1 trialAll trials in Jaú, Brazil
- Katowice, Poland 1 trialAll trials in Katowice, Poland
- Los Angeles, United States 1 trialAll trials in Los Angeles, United States
- Genoa, Italy 1 trialAll trials in Genoa, Italy
- Samsun, Turkey (türkiye) 1 trialAll trials in Samsun, Turkey (türkiye)
- Jerusalem, Israel 1 trialAll trials in Jerusalem, Israel
- Pozuelo de Alarcón, Spain 1 trialAll trials in Pozuelo de Alarcón, Spain
- Brno, Czechia 1 trialAll trials in Brno, Czechia
- Modena, Italy 1 trialAll trials in Modena, Italy
- Stony Brook, United States 1 trialAll trials in Stony Brook, United States
- Perugia, Italy 1 trialAll trials in Perugia, Italy
- Mainz, Germany 1 trialAll trials in Mainz, Germany
- Kraków, Poland 1 trialAll trials in Kraków, Poland